HNRNPA2B1 and urinary bladder carcinoma: However, we found that expression of FMR1 and HNRNPA2B1 were not correlated with the overall survival in bladder cancer patients based on TCGA-BLCA dataset, who were not treated with immunotherapy (Supplementary Figure S6).